Drug intelligence / Profile preview

CuminUP30

Development stage
Unknown
Lead developer
Chenland Nutritionals
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Oral
01

Overview

CuminUP30 is a proprietary formulation of curcumin, the principal bioactive compound in turmeric (Curcuma longa). It is produced using patented CGSF (Co-Grinding Solvent-Free) technology to enhance the water dispersibility and bioavailability of curcumin. The product contains more than 30% curcumin with a natural extraction content of 95%, combined with food-grade excipients through microprocessing. CuminUP30 is marketed as a nutraceutical supplement intended to support immune health, joint function, energy levels, liver and brain health, and healthy inflammatory responses. Its mechanism of action derives from curcumin’s pleiotropic effects—antioxidant activity, anti-inflammatory properties via modulation of multiple cellular signaling pathways (including inhibition of NF-κB), and potential inhibition of enzymes such as cytochrome P450 3A4 and inducible nitric oxide synthase[2][3][5][8]. Clinical studies have focused on its pharmacokinetics and improved bioavailability compared to standard curcumin formulations.

Brand names
CuminUP30CuminUP-30CuminUP 30
Other names
Curcumin UP 30Upgraded curcumin capsules
02

Targets

CYP3A4 (Cytochrome P450 3A4)NOS2 (Nitric Oxide Synthase 2)CA14 (Carbonic Anhydrase 14)

Beyond the preview

Go deeper on CuminUP30.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CuminUP30.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call